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itochondrial outer membrane permeabilization
by proapoptotic Bcl-2 family proteins, such as
Bax, plays a crucial role in apoptosis induction.
However, whether this only causes the intracytosolic release
of inducers of caspase-dependent death, such as cytochrome
 
c
 
, or also of caspase-independent death, such as apoptosis-
inducing factor (AIF) remains unknown. Here, we show
that on isolated mitochondria, Bax causes the release of
cytochrome 
 
c
 
, but not of AIF, and the association of AIF
with the mitochondrial inner membrane provides a simple
M
 
explanation for its lack of release upon Bax-mediated outer
membrane permeabilization. In cells overexpressing Bax or
treated either with the Bax- or Bak-dependent proapoptotic
drugs staurosporine or actinomycin D, or with hydrogen
peroxide, caspase inhibitors did not affect the intracytosolic
translocation of cytochrome 
 
c
 
, but prevented that of AIF.
These results provide a paradigm for mitochondria-dependent
death pathways in which AIF cannot substitute for caspase
executioners because its intracytosolic release occurs
downstream of that of cytochrome 
 
c
 
. 
 
Introduction
 
Most proapoptotic stimuli require a mitochondria-dependent
step, involving outer membrane permeabilization con-
trolled by pro- and antiapoptotic members of the Bcl-2
family and leading to intracytosolic release of mitochondria
intermembrane space proteins that can either trigger cas-
 
pase activation, such as cytochrome 
 
c
 
, or caspase-independent
death pathways, such as apoptosis-inducing factor (AIF;*
Martinou and Green, 2001; Zamzami and Kroemer,
2001). Bax is one of the main proapoptotic Bcl-2 family
proteins; the presence of either Bax or Bak being required
for most mitochondria-dependent cell death processes,
including those induced by tBid, the caspase-activated
form of the “BH3-domain only” proapoptotic Bcl-2 family
protein Bid and by proapoptotic drugs such as staurosporine
and actinomycin D (Wei et al., 2001). Bax has been reported
to induce cytochrome
 
 c 
 
release both in Bax-expressing cells
and in isolated mitochondria incubated with recombinant
oligomerized Bax (Eskes et al., 1998; Jurgenmeier et al.,
1998; Finucane et al., 1999; Antonsson et al., 2000).
However, whether Bax-mediated mitochondria outer mem-
brane permeabilization also induces the release of AIF
(Susin et al., 1999) is so far unknown.
Here, we show that the mitochondrial outermembrane
permeabilization induced either by Bax, by Bax- or Bak-
dependent proapoptotic drugs, or by hydrogen peroxide
(H
 
2
 
O
 
2
 
) results in the intracytosolic release of cytochrome 
 
c
 
,
but that subsequent caspase activation is required to induce
the translocation of AIF into the cytosol. These findings
identify the mitochondrial response to several proapoptotic
stimuli as a selective process leading to a hierarchical ordering
of the effectors involved in cell death induction. 
 
The online version of this article contains supplemental material.
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MP, mitoplast.
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Results and discussion
 
To investigate whether Bax may induce the mitochondrial
release of AIF, we incubated freshly purified mitochondria
from human HeLa cells with recombinant oligomeric Bax,
and performed Western Blot analysis of cytochrome
 
 c 
 
and
AIF in both the mitochondria supernatants and pellets. For
the detection of AIF, we used a pAb specific for human AIF
(Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200207071/DC1), obtained as indicated in Materials
and methods. Mitochondrial release of cytochrome
 
 c 
 
was
maximal for a Bax concentration of 100 nM (Fig. 1 A), and
a kinetic analysis indicated that cytochrome
 
 c 
 
release was
rapid; almost completed in 15 min (Fig. 1 B). In contrast,
Bax did not induce any detectable mitochondrial release of
AIF after incubations for 30 min with Bax concentrations
up to 200 nM (Fig. 1, A and B). Because the isolated mito-
chondria we used were purified from HeLa cancer cells, and
because cancer cells accumulate various alterations that fa-
vor cell death repression (Evan and Littlewood, 1998), we
investigated the response of mitochondria from primary
cells. Using another commercially available pAb specific for
AIF, we explored the response of mitochondria from rat
primary liver cells to either oligomeric Bax or to a form of
oligomerized Bax obtained by mixing recombinant mono-
meric Bax with low concentrations of recombinant tBid.
Although neither 100 nM monomeric Bax nor 10 nM tBid
alone had any effect, together they induced the release of
cytochrome 
 
c
 
, but not of AIF (Fig. 1 C), as oligomeric Bax
(unpublished data). At higher concentrations (50 or 100
nM), tBid by itself also induced the release of cytochrome 
 
c
 
,
but not of AIF (Fig. 1 D). Because tBid requires the pres-
ence of endogenous Bak on mitochondria to induce cyto-
chrome
 
 c 
 
release from isolated murine liver cell mitochon-
dria (Wei et al., 2000), tBid alone probably acted through
the formation of tBid/Bak oligomers. Together, our data
indicated that the lack of AIF release did not depend on the
 
cell (primary or cancer) or species (human or rat) origin of
the mitochondria.
AIF was originally described as a soluble protein localized
in the mitochondrial intermembrane space (Susin et al.,
1999). Therefore, a possible explanation for our findings was
that Bax and tBid induce the formation of selective outer
membrane pores (Martinou and Green, 2001), allowing the
passage of cytochrome
 
 c 
 
but not of AIF. Alternately, Bax and
tBid cause a nonselective process of outer membrane perme-
abilization (Zamzami and Kroemer, 2001), but AIF is not an
intermembrane space–soluble protein. To discriminate be-
tween these two possibilities, we explored the localization of
AIF and cytochrome
 
 c 
 
in subfractions of purified mitochon-
dria from rat primary liver cells. When compared with its
total amount in whole mitochondria, only a part of cy-
tochrome
 
 c 
 
colocalized both with the mitoplasts (MP), ob-
tained after outer membrane removal and consisting of the
mitochondrial inner membranes (MIMs) and the matrix,
and with the enriched, purified inner membranes (Fig. 2 A).
In contrast, around the same amount of AIF colocalized with
whole mitochondria, MP, and MIM, suggesting an absence
of soluble AIF in the intermembrane space (Fig. 2 A). To in-
vestigate whether AIF is an integral component of the inner
membrane or is rather peripherally associated with it, we
subjected the MPs to sodium carbonate treatment. The al-
kali treatment caused a complete loss of AIF colocalization
with the MPs, whereas the cytochrome
 
 c 
 
oxidase subunit IV
(Cox IV) protein, an integral component of the inner mem-
brane, was unaffected (Fig. 2 B). Together, these findings in-
dicated that most AIF is peripherally associated with the mi-
tochondrial inner membrane, presumably with its external
side, and suggested that the outer membrane permeabiliza-
tion induced by Bax or tBid is not sufficient to allow the de-
tachment of AIF from the inner membrane.
Next, we investigated whether the mitochondrial release
of cytochrome
 
 c 
 
may also be dissociated from that of AIF in
Figure 1. Oligomeric Bax, Bax/tBid oligomers, 
and tBid induce the release of cytochrome c, but 
not of AIF from isolated mitochondria. (A) Mito-
chondria isolated from HeLa cells were incubated 
for 30 min at 30 C with different concentrations 
(nM) of recombinant oligomeric Bax. Mitochondrial 
pellets and supernatant fractions were separated 
by SDS-PAGE, and their respective contents in AIF 
and cytochrome c (Cyt c) analyzed by Western 
blotting. (B) Mitochondria isolated from HeLa cells 
were incubated with 200 nM oligomeric recombinant 
Bax or with control buffer (none) at 30 C, and the 
mitochondria pellet and supernatant were analyzed 
at different time points (min), as in A. Asterisk in A 
and B indicates an additional band. (C) Mitochondria 
freshly isolated from rat liver cells were incubated 
for 15 min in the absence or presence of 100 nM 
recombinant monomeric Bax and/or 10 nM 
recombinant tBid, and analyzed as in A. (D) Mito-
chondria freshly isolated from rat liver cells were 
incubated for 30 min in the absence or presence of 
50 or 100 nM recombinant tBid, and analyzed as 
in C. In all experiments, equal loading of the 
mitochondrial pellet was controlled using an 
mAb against either VDAC or cytochrome c oxidase 
subunit IV (Cox IV).  
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cells overexpressing Bax. Bax-mediated mitochondrial re-
lease of cytochrome
 
 c 
 
does not require caspase activation and
occurs in the presence of caspase inhibitors (Eskes et al.,
1998; Finucane et al., 1999; Martinou and Green, 2001).
We transiently transfected human 293T cells with an ex-
pression vector encoding Bax, in the absence or presence of
the broad caspase inhibitor peptide z-VAD-fmk (100 
 
 
 
M),
and performed a kinetic Western blot analysis. Bax expres-
sion led to a time-dependent increase in intracytosolic release
of cytochrome
 
 c 
 
and AIF, caspase-9, and caspase-3 process-
ing, PARP cleavage, and cell death (Fig. 3 A). z-VAD-fmk
did neither prevent Bax expression nor Bax-induced intracy-
tosolic release of cytochrome 
 
c
 
, but prevented cell death in-
duction (Fig. 3 A), nuclear DNA degradation (hypodip-
loidy) and mitochondrial transmembrane potential (
 
  
 
m)
loss (Fig. S2), caspase-9, and caspase-3 processing, PARP
cleavage, and the intracytosolic release of AIF (Fig. 3 A).
100
 
 
 
M BAF, another broad caspase inhibitor, showed the
same effect as z-VAD-fmk, preventing both cell death and
the release of AIF, but not the release of cytochrome
 
 c 
 
(Fig. 3
B). To confirm these findings, we used immunofluorescence
microscopy analysis to compare the localization of Bax, cyto-
chrome 
 
c
 
, AIF, and Hsp60 (a protein of the mitochondria
matrix) in HeLa cells 18 h after transfection with a vector
expressing GFP-Bax, in the absence or presence of z-VAD-
fmk. Some nonspecific nuclear staining was induced by the
polyclonal anti-AIF antibody (Fig. S1), and also by the con-
trol sera (unpublished data) in control HeLa cells. z-VAD-
fmk prevented the induction of nuclear features of apoptosis
in GFP-Bax–expressing cells (Fig. 3 C), but did neither pre-
vent the induction of a punctuated cytosolic staining of Bax,
that colocalized with Hsp 60, indicating an insertion of Bax
 
into mitochondria, nor the induction of a diffuse cytosolic
staining of cytochrome
 
 c 
 
(Fig. 3 C and D). In contrast,
z-VAD-fmk treatment prevented the induction of a diffuse
staining of AIF (Fig. 3, C and D), confirming that Bax did
not induce the mitochondrial release of AIF in the presence
of caspase inhibitors.
The proapoptotic drug staurosporine does not require the
presence of AIF to cause cell death (Joza et al., 2001), but re-
quires the presence of either Bax or Bak to induce mitochon-
drial release of cytochrome
 
 c 
 
and cell death (Wei et al.,
2001). We treated HeLa cells with 2 
 
 
 
M staurosporine for
9 h in the absence or presence of 100 
 
 
 
M z-VAD-fmk.
z-VAD-fmk prevented staurosporine-mediated apoptosis in-
duction (Fig. 4 A), as well as caspase-9 and caspase-3 pro-
cessing, PARP cleavage (Fig. 4 B), and the mitochondrial re-
lease of AIF (Fig. 4 C), but had no effect, as previously
reported (Goldstein et al., 2000), on the mitochondrial release
of cytochrome
 
 c 
 
(Fig. 4 C). Actinomycin D, as staurosporine,
requires the presence of Bax or Bak to induce cytochrome
 
 c
 
release and cell death (Wei et al., 2001). z-VAD-fmk also
prevented apoptosis induction by 10 
 
 
 
M actinomycin D
(16 
 
 
 
 5 versus 68 
 
 
 
 7), as well as mitochondrial release of
AIF, but not of cytochrome
 
 c 
 
(Fig. 4 D).
Because staurosporine induced a rapid and marked cell
shrinkage even in the presence of z-VAD-fmk, immunofluo-
rescence studies were difficult to interpret (unpublished data).
In contrast, cells did not undergo marked shrinkage when
treated with actinomycin D and z-VAD-fmk. Therefore, we
performed immunofluorescence analysis of cytochrome
 
 c 
 
and
AIF in HeLa cells treated with actinomycin D, and observed
that z-VAD-fmk prevented the mitochondrial release of AIF,
though having no effect on the release of cytochrome
 
 c 
 
(Fig.
4, E and F). For further confirmation, we increased the de-
tectability of AIF by overexpressing full-length human AIF in
HeLa cells. 18 h after AIF transfection, we treated the HeLa
cells for 9 h with actinomycin D in the absence or presence of
z-VAD-fmk, and observed the same pattern of cytochrome
 
 c
 
release and lack of AIF release in the cells treated with both
actinomycin D and z-VAD-fmk (Fig. 4 G).
Cell death due to the mitochondrial release of AIF has
been reported to occur in the presence of caspase inhibitors
in response to certain stimuli (Joza et al., 2001; Pardo et al.,
2001), including H
 
2
 
O
 
2
 
 (Yu et al., 2002). Using an AIF-spe-
cific mAb that did not induce background nuclear staining,
we performed immunofluorescence analysis of HeLa cells
treated with 400 
 
 
 
M H
 
2
 
O
 
2
 
 in the absence or presence of
z-VAD-fmk. As in Bax-expressing and in actinomycin
D–treated cells, z-VAD-fmk prevented both apoptosis and
AIF release in H
 
2
 
O
 
2
 
-treated cells, while not affecting cyto-
chrome
 
 c 
 
release (Fig. 5, A–C). Higher H
 
2
 
O
 
2
 
 concentrations
caused necrotic cell death but did not induce AIF release in
the presence of z-VAD-fmk (unpublished data). The very re-
cent paper that intramitochondrial AIF acts as a free radical
scavenger decreasing H
 
2
 
O
 
2
 
-mediated cell death (Klein et al.,
2002) is consistent with the notion that AIF is not a selective
effector of H
 
2
 
O
 
2
 
-induced death. Whether particular stimuli
may allow a selective caspase-independent process of AIF re-
lease remains to be confirmed. Our observation that AIF is
not a soluble mitochondrial intermembrane space protein,
but rather is attached to the inner membrane, provides a
Figure 2. AIF is associated with the mitochondrial inner membrane. 
(A) Rat liver cell mitochondria (M), mitoplasts (Mp), mitochondrial 
inner membrane (MIM), and mitochondrial outer membrane 
(MOM), were resolved by SDS-PAGE, and their respective contents 
in AIF, cytochrome c (Cyt.c), Cox IV, and VDAC were analyzed by 
Western blotting. (B) Mp (that consists of the MIM and matrix) were 
further treated with 0.1 M sodium carbonate (Na2CO3), pH 11.5, 
for 30 min on ice and pelleted by centrifugation. VDAC, an integral 
component of MOM, is present in M and MOM, but also detectable 
at low levels in Mp and MIM, as VDAC is present at MIM/MOM 
junctions that seem unaffected by treatments used to separate 
MIM and MOM. Because at equal protein concentrations, MOM 
are enriched for VDAC, there is less VDAC in M than in MOM. 
Cox IV, an integral component of MIM, is present in M, Mp, and 
enriched in MIM, but lacking in MOM, and remains in Mp after 
Na2CO3 treatment. 
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simple potential explanation for our findings, and for recent
findings by others, indicating that AIF is not among the pro-
teins released by isolated mitochondria on incubation with
tBid (Van Loo et al., 2002). Our observation that caspase
inhibitors prevent AIF release in cells exposed to several
proapoptotic stimuli, including Bax, Bax- or Bak-dependent
proapoptotic drugs, and H
 
2
 
O
 
2
 
 strongly suggests that activa-
tion of given caspases after mitochondrial outer membrane
permeabilization may be the limiting step for AIF detach-
ment from the inner membrane and intracytosolic release.
Figure 3. Caspase inhibitors prevent mitochondrial release of AIF in Bax-
overexpressing cells. (A) Western blot analysis of AIF and cytochrome c (Cyt 
c) release in the cytosolic fraction, and of Bax expression, caspase-9 (Casp-9), 
and caspase-3 (Casp-3) processing and PARP cleavage in total cell extracts 
(total) at various time points after transient transfection of 293T cells with 
either a vector encoding HA-Bax (Bax) or the empty control vector (vector), 
in the absence ( ) or presence ( ) of the caspase inhibitor z-VAD-fmk (100 
 M). Actin was used as loading control. Asterisk indicates the HA-Bax, the 
NH2-terminal HA-tag providing an additional molecular mass of  1.5 kD. 
(B) The cytosolic fraction of Bax transfected 293 T cells in the absence or 
presence of the caspase inhibitor BAF (100  M) was analyzed by Western 
blotting for cytochrome c (Cyt c) and AIF release, as in A. (C) GFP-Bax 
expression, and immunostaining of Hsp60, cytochrome c (Cyt c), and AIF together with nuclear Hoechst staining in HeLa cells 18 h after transient 
transfection with a vector encoding GFP-Bax in the absence ( zVAD-fmk) or presence ( zVAD-fmk) of the caspase inhibitor z-VAD-fmk 
(100  M). Nuclear staining by the polyclonal anti-AIF antibody is nonspecific, and also induced by control sera (not depicted). (D) Quantitative 
analysis of the numbers of GFP-Bax–transfected cells with intracytosolic release of cytochrome c and/or AIF in the absence or presence of 
100  M z-VAD-fmk. Each histogram indicates mean   SD of three fields of at least 100 cells within a representative experiment. 
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Figure 4. Caspase inhibitor prevents mitochondrial release of AIF in 
cells treated with proapoptotic drugs. (A) Percentages of cells with 
apoptotic nuclei (% of apoptotic nuclei) was determined as indicated 
in Materials and methods in HeLa cells treated for 9 h with 2  M stauro-
sporine in the absence or presence of 100  M z-VAD-fmk. (B) Total 
extract of the these cells was analyzed by Western blotting for cas-
pase-9 (casp-9) and caspase-3 (casp-3) processing and PARP cleavage. 
(C) Cytosolic fraction and heavy membrane fraction from these cells was 
analyzed by Western blotting for the presence of cytochrome c (Cyt c)
and AIF. As control for loading, actin was used in the cytosolic fraction 
and Cox IV in the heavy membrane fraction. (D) HeLa cells were either 
left untreated or treated for 9 h with 10  M actinomycin D in the presence 
or absence of 100  M z-VAD-fmk, then cytosolic fraction and heavy 
membrane fraction were analyzed as in C. (E) The cells were also immunostained with the anti–cytochrome c (Cyt c) and anti-AIF anti-
bodies together with Hoechst nuclear staining. (F) Quantitative analysis of the numbers of actinomycin D–treated cells with intracytosolic 
release of cytochrome c and/or AIF in the absence or presence of 100  M z-VAD-fmk. Each histogram indicates mean   SD of three 
fields of at least 100 cells within a representative experiment. (G) HeLa cells were transiently transfected for 18 h with a vector encoding 
full length AIF, and then either left untreated (Control) or treated for 9 h with 10  M actinomycin D in the presence or absence of 100 
 M z-VAD-fmk, and then immunostained with the anti–cytochrome c (Cyt c) and anti-AIF antibodies together with Hoechst nuclear 
staining. Arrows in E and G indicate cells showing intracytosolic release of cytochrome c.928 The Journal of Cell Biology | Volume 159, Number 6, 2002
However, because caspase inhibitors may also prevent the
activity of other proteases (Wolf et al., 1999), the precise
pathway leading to AIF release downstream of cytochrome c
release remains to be investigated.
Here, we have identified the mitochondrial response to
Bax and other proapoptotic stimuli as a very selective process
leading to a hierarchical ordering of the effectors involved in
cell death induction. Our findings provide a paradigm for
mitochondria-dependent cell death pathways involving a
postmitochondrial level of pharmacological and possibly en-
dogenous regulation that precedes the intracytosolic release
of the caspase-independent death effector AIF. 
Materials and methods
Mitochondria isolation and in vitro cytochrome c and AIF release
Mitochondria were isolated from HeLa cells and rat liver by sucrose den-
sity gradient centrifugation, and in vitro cytochrome c and AIF release was
assessed as described previously (Eskes et al., 1998; Desagher et al., 1999).
Production of full-length recombinant oligomeric, monomeric Bax and
monomeric tBid (Antonsson et al., 2000; Kudla et al., 2000), and prepara-
tion of mitochondrial membrane vesicles from rat liver mitochondria
(Mayer et al., 1993) were performed as described previously.
Cell culture and transfection
HEK 293T and HeLa cells were cultured in DME (GIBCO BRL) supple-
mented with 10% FCS, 2 mM L-glutamine, 50 IU penicillin, and 50
 g ml
 1 streptomycin under standard conditions. Transient transfections of
293T and of HeLa cells were performed using calcium phosphate and Li-
pofectAMINE™ (GIBCO BRL), respectively. pcDNA-AIF (Susin et al.,
1999) was provided by G. Kroemer and S. Susin (CNRS-UMR 8125, Insti-
tut Gustave Roussy, Villejuif, France).
Cell death measurement
At different time points after transfection or drug treatment, cells were re-
covered after incubation in PBS containing 1 mM EDTA, washed in PBS,
and fixed with 4% PFA. Nuclei were then colored with Hoechst 33342
(Sigma-Aldrich). Green cells with blebbing, shrinkage, and apoptotic (con-
densed and fragmented) nuclei were considered as dying.
Subcellular fractionation
Cells were harvested in isotonic mitochondrial buffer (210 mM mannitol, 70
mM sucrose, 1 mM EDTA, and 10 mM Hepes, pH 7.5) supplemented with
protease inhibitor cocktail Complete (Boehringer), and homogenized for 30–
40 strokes with a Dounce homogenizer. Samples were transferred to Eppen-
dorf centrifuge tubes and centrifuged at 500 g for 5 min at 4 C to eliminate
nuclei and unbroken cells. Supernatant was then centrifuged at 10,000 g for
30 min at 4 C to obtain the heavy membrane pellet enriched for mitochon-
dria, and the resulting supernatant was stored as the cytosolic fraction.
Protein studies
Preparation of cellular lysates, immunoblotting, and immunofluorescence
were performed as described previously (Desagher et al., 1999; Finucane
et al., 1999). Antibodies used in immunoblotting were as follows: mouse
mAb against cytochrome c (clone 7H8.2C12; PharMingen), PARP (BD Bio-
sciences), Bax (N20; Santa Cruz Biotechnology, Inc.), VDAC (Calbiochem),
Cox IV (Molecular Probes, Inc.), or actin (Sigma-Aldrich), and rabbit pAbs
specific for caspase-9 (Cayman Chemical). For human AIF detection, we
used a rabbit polyclonal anti-AIF antibody that we obtained from rabbits
immunized against a mixture of three different human AIF peptides (amino
acids 106–120, 512–526, and 588–602). Each peptide was detected by the
anti-AIF antibodies up to the dilution of 1/10,000 by ELISA. The anti-AIF
antibody also detected recombinant human AIF protein (Susin et al., 1999),
provided by G. Kroemer and S. Susin. For rat AIF detection, we used a goat
polyclonal anti-AIF antibody (D-20; Santa Cruz Biotechnology, Inc.). All
antibodies were used at dilution 1/1,000, then visualized using HRP-conju-
gated secondary antibodies (Amersham Biosciences), followed by en-
hanced chemiluminescence (Amersham Biosciences). Antibodies used in
immunofluorescence were as follows: our rabbit polyclonal antibody
against human AIF (1/200) or in Fig. 5, a commercially available mouse
IgG2b mAb against human AIF (AIF [E-1]; Santa Cruz Biotechnology, Inc.)
Figure 5. AIF release is caspase dependent in H2O2-mediated 
cell death. (A) Percentages of apoptotic nuclei were determined 
in HeLa cells treated for 6 h with 400  M H2O2 in the absence or 
presence of 100  M z-VAD-fmk. (B) HeLa cells were treated as in 
A and immunostained with a sheep anti–cytochrome c (Cyt c) and 
a mouse anti-AIF mAb together with Hoechst nuclear staining. 
(C) Quantitative analysis of the numbers of H2O2-treated cells 
with intracytosolic release of cytochrome c and/or AIF in the
absence or presence of 100  M z-VAD-fmk. Each histogram 
indicates mean   SD of three fields of at least 100 cells within 
a representative experiment. Caspase-dependent AIF release | Arnoult et al. 929
(1/50), that was raised against a recombinant protein corresponding to
amino acids 1–300 of human AIF; an anti–cytochrome c mAb (6H2.B4,
1/200; BD Biosciences) or a sheep polyclonal anti–cytochrome c (1/600;
Sigma-Aldrich), and an anti-Hsp60 mAb (1/200; StressGen Biotechnolo-
gies). Antibodies were then detected using TRITC-labeled or FITC-labeled
secondary antibody (1/200), and cells examined under a UV Fluorescence
Microscope (3CCD; Leica) or a Confocal Microscope (LSM 510; Carl Zeiss
MicroImaging, Inc.).
Online supplemental material
The specificity of our rabbit polyclonal antibody against human AIF was
assessed by Western blotting and immunofluorescence assays (Fig. S1).
The preventive effect of the caspase inhibitor z-VAD-fmk on Bax-induced
cell death was investigated by flow cytometry analysis of DNA degra-
dation and mitochondrial permeability (  m) loss in Bax-transfected 293
T cells (Fig. S2). Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200207071/DC1.
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Note added in proof. While our paper was in proof, it was reported that
the mitochondrial release of the AIF homologue WAH-1 is also caspase
(CED-3) dependent in the nematode Caenorhabditis elegans (Wang, X., C.
Yang, J. Chai, Y. Shi, D. Xue. 2002. Science. 298:1587–1592). Thus, the
process that we describe here, in mammalian cells, may be evolutionarily
conserved.
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